NCT05887492TNG260pembrolizumabTNG260-inducedNSCLCNon-small cell lung cancerimmune checkpoint-based therapies
…ombination with pembrolizumab in advanced STK11-mutant cancers (NCT05887492).Methods Informed by in vivo CRISPR screens, we identified CoRE…